Shim Ching
Plastic and Reconstructive Surgery · Honolulu, HINPI 1184670689
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (41.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 92.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $22,214 and has fallen 88.2% since, to $2,612 in 2025.
Across 369 payments — averaging $131.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$45K
- Merz North America, Inc.$1K
- Revance Therapeutics, Inc.$511
- Integra Lifesciences Corporation$326
- Surgical Innovation Associates, Inc.$323
- Galderma Laboratories, L.p.$314
- plus $873 from 13 others
What the payments were for
- Speaking & faculty fees$18,17637%
- Food & beverage$9,30419%
- Education$2080%
- Gifts$20,29542%
- Other$7071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 294 | $45,218 |
| Merz North America, Inc. | 10 | $1,124 |
| Revance Therapeutics, Inc. | 21 | $511 |
| Integra Lifesciences Corporation | 1 | $326 |
| Surgical Innovation Associates, Inc. | 1 | $323 |
| Galderma Laboratories, L.p. | 17 | $314 |
| Sientra, Inc. | 1 | $211 |
| Motiva USA, LLC | 2 | $145 |
| Kowa Pharmaceuticals America, Inc. | 5 | $110 |
| TELA Bio, Inc. | 1 | $87 |
| Mentor Worldwide LLC | 4 | $74 |
| KARL Storz Endoscopy-america | 3 | $58 |
| Coopersurgical, Inc. | 3 | $57 |
| Apollo Endosurgery US Inc | 1 | $34 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $24 |
| Novo Nordisk | 1 | $23 |
| Kls-martin L.p. | 1 | $20 |
| Davol Inc. | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic and reconstructive surgery providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Hcl | 18 | $103 |
| Ondansetron OdtOndansetron | 19 | $90 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Honolulu
- Peter DeptulaHonolulu$18K
- Randolph WongHonolulu$7K
- Vincent NipHonolulu$7K
- Robert SchulzHonolulu$4K
- Zachary LongHonolulu$2K
- Matthew AdaniyaHonolulu$2K
- Michael PasqualeHonolulu$904
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.